These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6404207)

  • 1. Clinical use of the new beta-lactam antimicrobial drugs. Practical considerations for physicians, microbiology laboratories, pharmacists, and formulary committees.
    Brooks GF; Barriere SL
    Ann Intern Med; 1983 Apr; 98(4):530-5. PubMed ID: 6404207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of antimicrobial agents for routine testing in a clinical microbiology laboratory.
    Jorgensen JH
    Diagn Microbiol Infect Dis; 1993; 16(3):245-9. PubMed ID: 8477580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial formulary management: meeting the challenge in the community hospital.
    Rush DR
    Pharmacotherapy; 1991; 11(1 ( Pt 2)):19S-26S. PubMed ID: 2011569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Third generation cephalosporin use in a tertiary hospital in Port of Spain, Trinidad: need for an antibiotic policy.
    Pinto Pereira LM; Phillips M; Ramlal H; Teemul K; Prabhakar P
    BMC Infect Dis; 2004 Dec; 4(1):59. PubMed ID: 15601475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of beta-lactam nonsusceptible Gram-negative bacilli and use and interpretation of current susceptibility breakpoints: a survey of infectious disease physicians.
    Kallen AJ; Beekmann SE; Limbago B; Lentnek AL; Polgreen PM; Patel J; Srinivasan A
    Diagn Microbiol Infect Dis; 2011 Nov; 71(3):316-9. PubMed ID: 21899980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic guidelines and antibiotic utilization in Dutch hospitals.
    Stobberingh E; Janknegt R; Wijnands G
    J Antimicrob Chemother; 1993 Jul; 32(1):153-61. PubMed ID: 8226406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effective antimicrobial therapy: an approach for physicians and community hospitals.
    Bryan CS; Ervin FR; John JF; Richards VR
    J S C Med Assoc; 1986 Mar; 82(3):121-248. PubMed ID: 3084868
    [No Abstract]   [Full Text] [Related]  

  • 8. A five-year analysis of antimicrobial susceptibility testing profiles for beta-lactam antimicrobials, with inter-hospital and susceptibility method comparisons within a medical school affiliated hospital system.
    Matsen JM; Fenn JP; Abbott TM; Saxon BA; Johnson CC; Hill GA
    Chemioterapia; 1985 Feb; 4(1):71-7. PubMed ID: 3921266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of extended-spectrum beta-lactams on gram-negative bacterial resistance.
    Paladino JA; Sunderlin JL; Singer ME; Adelman MH; Schentag JJ
    Am J Health Syst Pharm; 2008 Jun; 65(12):1154-9. PubMed ID: 18541686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activities, functions, and structure of pharmacy and therapeutics committees in large teaching hospitals.
    Mannebach MA; Ascione FJ; Gaither CA; Bagozzi RP; Cohen IA; Ryan ML
    Am J Health Syst Pharm; 1999 Apr; 56(7):622-8. PubMed ID: 10423208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Potential β-Lactam Surrogates To Predict
    Hackel MA; Iaconis JP; Karlowsky JA; Sahm DF
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29436424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of antimicrobial resistance in gram-negative bacilli causing bacteremia during therapy.
    Siebert JD; Thomson RB; Tan JS; Gerson LW
    Am J Clin Pathol; 1993 Jul; 100(1):47-51. PubMed ID: 8346736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of susceptibility to beta-lactam antimicrobial agents among bacteria isolated from intensive care units.
    Pierson CL; Friedman BA
    Diagn Microbiol Infect Dis; 1992 Feb; 15(2 Suppl):19S-30S. PubMed ID: 1737439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Beta-lactam antibiotics].
    Suárez C; Gudiol F
    Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):116-29. PubMed ID: 19254642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity of beta-lactams against multiresistant micro-organisms from the family Enterobacteriaceae, and genus Pseudomonas.
    Niebla A; González I; Vallín C
    Microbios; 1994; 80(325):245-50. PubMed ID: 7700163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a pharmacist-driven beta-lactam allergy interview on inpatient antimicrobial therapy: A pilot project.
    Sigona NS; Steele JM; Miller CD
    J Am Pharm Assoc (2003); 2016; 56(6):665-669. PubMed ID: 27745795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of CLSI Breakpoint Changes on Microbiology Laboratories and Antimicrobial Stewardship Programs.
    Heil EL; Johnson JK
    J Clin Microbiol; 2016 Apr; 54(4):840-4. PubMed ID: 26791363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic/pharmacodynamic target attainment of intravenous β-lactam regimens against Gram-negative bacteria isolated in a Brazilian teaching hospital.
    Furtado GH; Cardinal L; Macedo RS; Silva JO; Medeiros EA; Kuti JL; Nicolau DP
    Rev Soc Bras Med Trop; 2015; 48(5):539-45. PubMed ID: 26516962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-lactams in continuous infusion for Gram-negative bacilli osteoarticular infections: an easy method for clinical use.
    Ribera A; Soldevila L; Rigo-Bonnin R; Tubau F; Padullés A; Gómez-Junyent J; Ariza J; Murillo O
    Infection; 2018 Apr; 46(2):239-244. PubMed ID: 29363049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Institution-specific versus published in vitro antimicrobial susceptibility data in making formulary decisions.
    Franson TR; DaMert GJ; Sheth NK; Wisniewski T; Cooper JE; Johnson R; Babcock JB; Hoffmann RG; Malangoni MA
    Am J Hosp Pharm; 1987 Jan; 44(1):95-101. PubMed ID: 3826095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.